Shasun Chemicals gets USFDA approval

Chennai, July 5: Shasun Chemicals and Drugs, a pharma company focused on manufacture of finished dosage forms, Active Pharmaceutical Ingredients and intermediates for global pharma firms, today announced that the US Food and Drug Administration (USFDA) has approved the company's formulation facility in Puducherry.

''With the formulation facility having already been successful in the UK and now USFDA audit, we are in the process of diversifying our business by making a foray into formulation exports, predominantly into regulated markets such as the US, Canada and Europe,'' company CEO Govindarajan said in a release here.

''We have also forged marketing alliances with two multinational companies and expect launch of the products in the US by 2008,'' he added.

Mr Govindarajan said the partners of Shasun have filed three Abbreviated New Drug Applications (ANDAs) and were expected to file another nine in this financial year.

''The formulation business would start contributing revenue from this year and is expected to ramp up Rs 100 crore by 2010,'' he added.

UNI